NCT02014337: Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors |
|
|
| Completed | 1 | 37 | US | Mifepristone and Eribulin in combination, Korlym®, Halaven | Corcept Therapeutics | Breast Cancer, Ovarian Epithelial Cancer Recurrent, Sarcoma, Non-small Cell Lung Cancer, Carcinoma, Transitional Cell, Prostate Cancer, Prostatic Neoplasms | 12/17 | 12/17 | | |